港股午评|恒生指数早盘涨0.11% 创新药概念延续涨势

Group 1 - The Hang Seng Index rose by 0.11%, gaining 26 points to close at 24,166 points, while the Hang Seng Tech Index increased by 0.20% [1] - Multiple policies have been introduced to support the high-quality development of innovative drugs, with the commercial insurance innovative drug catalog expected to be implemented, leading to a continued rise in innovative drug stocks [1] - Companies such as Boan Biotech (06955) surged by 14%, Hengrui Medicine (01276) increased by 4.78%, and Lijun Pharmaceutical (01513) rose by 6% [1] Group 2 - Sipai Health (00314) saw a rise of over 5% as the National Healthcare Security Administration plans to create a commercial insurance innovative drug catalog, which is expected to significantly benefit the company [2] - Okex Cloud Chain (01499) surged over 29% as Bitcoin surpassed $120,000, setting a new historical high [2] - The construction materials sector is experiencing a boost due to ongoing policy support aimed at reducing competition, with companies like China National Building Material (03323) rising over 8% [2] Group 3 - Ganfeng Lithium (01772) and Tianqi Lithium (09696) saw their main lithium carbonate contracts rise over 6% and 4% respectively, reflecting strong market demand [4] Group 4 - Kexuan Power Holdings (00476) experienced a decline of over 30%, with annual losses attributable to shareholders increasing by 16.5% year-on-year [5] - Blukoo (00325) dropped 5.5% in early trading, with its stock price having retreated by 30% over the past month following a recent unlock of shares [6]